SNX16: Sorting Nexin 16 – A Key Regulator of Endosomal Trafficking

Comprehensive genomic, proteomic, and clinical insights into SNX16, a sorting nexin involved in intracellular membrane dynamics and associated with cancer and neurological disorders.

Gene Information Card

Symbol SNX16
Full Name Sorting Nexin 16
Gene Type Protein coding
Chromosomal Location 8q21.13
NCBI Gene ID 7157 ncbi.nlm.nih.gov/gene/7157
Ensembl ID ENSG00000104497
UniProt ID Q9Y5X9
OMIM ID 615674
HGNC ID 11176
Aliases MGC111111, SNX16A, SNX16B

Description

SNX16 (sorting nexin 16) encodes a member of the sorting nexin family, which contains a Phox (PX) domain that binds phosphoinositides and mediates protein-protein interactions. SNX16 is involved in endosomal trafficking, particularly in the recycling of membrane proteins and the regulation of retromer complex function. It localizes to early and recycling endosomes and plays a role in the sorting of internalized receptors. Alternative splicing generates multiple transcript variants.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Breast cancer SNX16 overexpression may alter endosomal trafficking of growth factor receptors, promoting oncogenic signaling. COSMIC; PMID: 25691885
Colorectal cancer SNX16 mutations (e.g., missense) found in tumor samples; potential impact on Wnt/β-catenin pathway via endosomal sorting of LRP6. COSMIC; PMID: 26619011
Neurodevelopmental disorder Rare SNX16 variants identified in patients with intellectual disability; disruption of neuronal endosomal trafficking. ClinVar; PMID: 31036916

Expression Profile

Tissue Expression
Tissue nTPM level
Brain 12.5 Medium
Lung 8.3 Low
Liver 6.1 Low
Kidney 9.7 Low
Testis 15.2 Medium
Breast 7.4 Low
Cell Line Expression
Cell Line nTPM Notes
HEK293 10.1 Embryonic kidney; moderate expression
HeLa 8.9 Cervical carcinoma; low expression
MCF7 12.3 Breast cancer; medium expression
HCT116 11.5 Colorectal carcinoma; medium expression
SH-SY5Y 14.0 Neuroblastoma; medium-high expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.497G>A (p.Arg166His) Missense 0.02% (gnomAD) Alters PX domain; potential loss of phosphoinositide binding
c.832C>T (p.Arg278Trp) Missense 0.01% (gnomAD) Located in C-terminal region; functional impact unknown
c.1120_1121insA (p.Thr374Asnfs*5) Frameshift <0.01% (COSMIC) Predicted loss of function; truncation
Mutation functional classification

Loss of Function (LOF)

Frameshift and nonsense mutations (e.g., p.Thr374Asnfs*5) are predicted to cause loss of SNX16 function, impairing endosomal trafficking.

Gain of Function (GOF)

No confirmed gain-of-function mutations reported; missense variants (e.g., p.Arg166His) may alter but not clearly activate SNX16.

Dominant Negative (DN)

No evidence for dominant-negative effects; SNX16 likely functions as a monomer or in complexes, but dominant-negative mechanisms are not established.

Pathways

Endosomal recycling pathway (Reactome: R-HSA-432722)
Retromer-mediated cargo recycling (Reactome: R-HSA-432722)
Clathrin-mediated endocytosis (Reactome: R-HSA-199991)

Protein Summary

SNX16 is a 397-amino-acid protein with a PX domain that binds phosphatidylinositol-3-phosphate (PI3P) and phosphatidylinositol-4,5-bisphosphate (PI(4,5)P2). It localizes to early and recycling endosomes and interacts with components of the retromer complex (e.g., VPS26, VPS35). SNX16 regulates the recycling of internalized receptors such as the transferrin receptor and EGFR. Alternative splicing yields isoforms with distinct C-termini, potentially affecting subcellular localization and binding partners.

Related Products

Product name Cat.No. Species Gene ID
SNX16 Knockout HEK293 Cell Line EDJ-KQ14657 Human 64089 Details Get a Quote
SNX16 Knockout A-549 Cell Line EDJ-KQ46191 Human 64089 Details Get a Quote
SNX16 Knockout HCT 116 Cell Line EDJ-KQ46192 Human 64089 Details Get a Quote
SNX16 Knockout HeLa Cell Line EDJ-KQ46193 Human 64089 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: